NSE: DRREDDY · 29 September 2026 · Dated market coverage
- The stock is +2.53% at ₹1,251.90.
- Likely reason:Strong volume-backed momentum and sector outperformance
- Approximate traded value is₹645.26 crore.
- It is -11.52% from its 52-week high and +13.71% from its 52-week low.
- The stock is being compared withNifty Pharmaalongside the Nifty 50.
Why Is Dr. Reddy S Laboratories Share Price Rising Today?
Latest NSE EOD report: 2026-09-29. Today’s Volume: 5,154,261; 5-Day Avg. Volume: 2,479,893; 20-Day Avg. Volume: 1,636,892; Volume vs 20-Day Avg.: 3.15x; Delivery Quantity: 2,450,987; Delivery %: 45.84%; Number of Trades: 116,376.
Dr. Reddy’s Laboratories shares advanced during the session, trading near the upper end of the day’s range. The stock opened at ₹1,243.60 and touched a high of ₹1,251.90 before settling at ₹1,251.90, reflecting a gain of 2.53% over the previous close of ₹1,221.00. Trading volume was markedly robust, standing at over 2.08 times its 5-day average and more than 3.15 times its 20-day average, signaling elevated market participation.
The broader market sentiment was slightly negative, with the Nifty index slipping 0.28%. However, Dr. Reddy’s outperformed both the broader market and its sector benchmark, Nifty Pharma, which posted a modest gain of 0.64%. The stock’s positive momentum builds on a steady short-term recovery, adding to a 3.38% return over the past five sessions and a 6.91% gain over the last 20 trading days.
While the upward price movement coincides with ongoing operational updates—such as its recent exclusive distribution agreement with Takeda Biopharmaceuticals for Qdenga in India—no single fresh corporate catalyst was announced today. Consequently, the price action reflects a continuation of recent positive momentum supported by strong delivery volumes and sector-relative strength rather than a direct, newly disclosed corporate trigger.
low confidence
- Daily price gain of 2.53% with the stock closing near the day’s high of ₹1,251.90
- Volume surging to 3.15x its 20-day average
- Outperformance against a weak Nifty index (-0.28%)
Ownership & Transaction Activity
WittyTrades Data Insight
Price Position:The stock is near the upper end of the day’s trading range.
Move From Open:+0.67%.
Intraday Range:1.79% of the previous close.
5-Day Performance:+3.38%; 20-Day Performance:+6.91%.
Latest Company Developments
What Should Traders and Investors Watch Next?
- Upcoming financial results for the quarter ending September 30, 2026, scheduled for October 23, 2026
- Execution progress on recent distribution partnerships such as the Takeda Qdenga agreement
- Regulatory updates regarding pending product approvals and exchange clarifications
Catalyst note:No single confirmed corporate catalyst drove today’s move; the advance reflects strong volume-backed momentum and outperformance against broader market weakness.
Frequently Asked Questions
What is the likely reason for today’s move?
The stock moved up 2.53% on heavy volume that was more than triple its 20-day average, outperforming a declining Nifty benchmark and gaining relative strength. Because no major new catalyst was released today, the move is best interpreted as continuation of recent positive momentum backed by strong market participation.
Is trading volume elevated?
Today’s volume is 5,154,261. The latest 20-day average available is 1,636,892, equivalent to about 3.15x of the recent average.
Before acting on this stock
Consult your own investment adviser before acting on any security. If you are interested in stock research or other available research categories, review theWittyTrades subscription plans and research segments.
Article by:WittyTrades Research Desk